Skip to the content
Avance Clinical Receives Frost & Sullivan’s 2026 Global Company of the Year Recognition for Excellence in Biotech CRO Leadership|Read more
Avance Clinical
  • Preclinical – ClinicReady

    Phase I / Early Phase

    Phase II+ / Late Phase

    Centers of Excellence

    • Central Nervous System (CNS)
    • Early Phase
    • Oncology
    • Renal & Cardiometabolic

    Why Avance Clinical?

    GlobalReady

    The Australian Advantage

    The North American Advantage

    The Asia Advantage

    The EU Advantage

    Technology

    GlobalReady by Avance Clinical

    GlobalReady by Avance Clinical

    Watch video

  • Our capabilities

    Clinical operations

    Data management

    Biostatistics

    Medical writing

    Quality assurance

    Patient recruitment

    Global scientific & regulatory affairs

    Global site partnership network

    Safety and Pharmacovigilance

    Australia Delivers Certainty for US Biotechs in 2025

    28 May 2025

    Australia Delivers Certainty for US Biotechs in 2025

    • Company news

    As regulatory uncertainty grows in the United States, US biotechs are increasingly looking to Australia as a stable and predictable launchpad for early-phase clinical trials.

    Read more
  • Biotech experience

    Specialist areas

    Central nervous system (CNS)

    Dermatology

    Endocrinology

    Infectious diseases

    Oncology

    Ophthalmology

    Rare disease & orphan drug

    Respiratory & allergy

    Delivering High-Quality Trials With Expert Consultation And Management In Cancer Research

    5 January 2025

    Delivering High-Quality Trials With Expert Consultation And Management In Cancer Research

    The rapidly evolving landscape of oncology clinical trials, driven by innovative technologies and deeper insights into cancer biology, presents unique challenges and opportunities for U.S. biotech companies.

    Read more
  • News & events

    • News
    • Events
    • Webinars
    • Knowledge center
    • Whitepapers

    About

    • Company overview
    • Meet the team
    • Careers
    • Working at Avance Clinical
    • Scholarships
    • Industry awards

    Contact

    • Contact us
    • Book a meeting
    • Request a proposal
    • Locations
Request A Proposal

White papers

  • Reset
The Biotech’s Case for Programmatic Oncology Development

15 May 2026

The Biotech’s Case for Programmatic Oncology Development

Read more
Avance Clinical
The GlobalReady Contract Research Organization for Biotechs

Avance Clinical is a full-service Contract Research Organization (CRO) with clinical operations in Australia, New Zealand, Asia, North America, and Europe.

Global HQ

Level 22, 91 King William Street
Adelaide, SA
Australia 5000

Phone: +61 8 8249 4788

For all media enquiries: media@avancecro.com

View all locations

CRO for Biotechs
  • Why Avance Clinical?
  • Preclinical – ClinicReady
  • Phase I / Early Phase
  • Phase II+ / Late Phase
  • GlobalReady
  • The Australian Advantage
  • The North American Advantage
  • The Asia Advantage
  • The EU Advantage
  • Technology
Capabilities
  • Our capabilities
  • Clinical operations
  • Data management
  • Biostatistics
  • Medical writing
  • Quality assurance
  • Patient Recruitment
  • Global Scientific & Regulatory Affairs
  • Global site partnership network
  • Safety and Pharmacovigilance
Therapeutic areas
  • Biotech experience
  • Specialist areas
  • Central nervous system (CNS)
  • Dermatology
  • Endocrinology
  • Infectious diseases
  • Oncology
  • Ophthalmology
  • Rare disease & orphan drug
  • Respiratory & allergy
About
  • Company overview
  • Meet the team
  • Careers
  • Working at Avance Clinical
  • Scholarships
  • Industry awards
News & events
  • News
  • Events
  • Webinars
  • Knowledge center
  • Whitepapers
Careers
Contact

© 2026 Avance Clinical. All Rights Reserved.

  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Anti Bribery & Corruption
Avance Clinical
Request A Proposal
  • Home
  • CRO for Biotechs
    • Why Avance Clinical?
    • Preclinical – ClinicReady
    • Phase I / Early Phase
    • Phase II+ / Late Phase
    • GlobalReady
    • The Australian Advantage
    • The North American Advantage
    • The Asia Advantage
    • The EU Advantage
    • Technology
  • Centers of Excellence
    • Central Nervous System (CNS)
    • Early Phase
    • Oncology
    • Renal & Cardiometabolic
  • Capabilities
    • Our capabilities
    • Clinical operations
    • Data management
    • Biostatistics
    • Medical writing
    • Quality assurance
    • Patient Recruitment
    • Global Scientific & Regulatory Affairs
    • Global site partnership network
    • Safety and Pharmacovigilance
  • Therapeutic areas
    • Biotech experience
    • Specialist areas
    • Central nervous system (CNS)
    • Dermatology
    • Endocrinology
    • Infectious diseases
    • Oncology
    • Ophthalmology
    • Rare disease & orphan drug
    • Respiratory & allergy
  • News & events
    • News
    • Events
    • Webinars
    • Knowledge center
    • Whitepapers
  • About
    • Company overview
    • Meet the team
    • Careers
    • Working at Avance Clinical
    • Scholarships
    • Industry awards
  • Careers
  • Contact
    • Contact us
    • Book a meeting
    • Request a proposal
    • Locations

What are you looking for?

Popular searches: Preclinical, Phase I, Phase II, GlobalReady

Close search